LL--Jonnie's specific words during the meeting was that they were coming out with a "more convenient form" of taking it. After the presentation (we had asked about Anatapup--they won't be focusing on that anytime here soon), I told him my sisters and I were also giving the Anatabloc to our dogs (my terrier for back issues, my sis lab for stiffness in hi hind quarters) and he reiterated to me personally that they would be coming out with a new formulation in the begiining of 2013--he made it seem like it would be VERY soon, but you know how that goes. When I spoke with another shareholder who is VERY knowledgeable, he had heard something about them coming out with a bottle with MORE pills. DOSING is very big with them right now, in trying to figure out the right amount. MY take from my convo with Jonnie though was that they were going to up the amount of anatabine in the pills so you actually can take less pills throughout the day. MY TAKE tho, we'll see what happens. As for the tobacco stuff, no, I think they are planning to let it go altogether....they will retain the IP (especially for the Star Cure liscening)--but the arriva and the other stuff, they are DONE with. They want to be known as a biopharma, not anything having to do with tobacco...principally because of the "She" or Shay? ammendment which precludes schools, universities and medical programs from affiliating with anyone who works with a harmful substance (e.g. tobacco). They believe that once the Flint Studies are announced, if they are as good as anticipated it is going to open up a whole new world in terms of wanting to check it out against other autoimmune diseases, and we could see a HUGGEEEEE wave of need come out for the product---if that wave hits (FINGERS CROSSED!!!)--they are ready and will have no problems handling the production. Their principle focus for 2013 is PROFITABILITY. They believe they are well on their way towards achieving that.
